September 5, 2017
Precision for Medicine Acquires Leading Rare Disease CRO, Agility ClinicalRead more...
July 18, 2017
Precision’s Clark and Marshall Advocate for Biomarker Data Management in Bioscience Technology Onlin...Discover more...
July 6, 2017
Precision for Medicine Expands Its Global Footprint for Oncology Development ServicesGet the story...
Precision for Medicine can help you find and extract the long-term value of innovative drugs
We develop your assays and manage global logistics, speeding to actionable answers. We use biomarkers to stratify patients, incomparably improving your R&D efficiency and success. We manage every aspect of your clinical trials from sites to biomarkers to diagnostics, all under a single roof. In short: we dramatically accelerate your pathway from proof of concept to drug approval.
Precision's David Parker Discusses CDx Development Relationships with Clinical Omics
Perspective: Convergence of CLIA and FDA Requirements: A Rationale Shift in the Regulatory Paradigm
The laboratory developed test (LDT) has proven to be a flexible, quick, lower-in... Discover more »
6 Critical Factors for Achieving Approval of Oncology Drugs
In this high-stakes, high-velocity environment of oncology drug development and... Discover more »